SAO PAULO (Reuters) -Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug ...

Healthcare & Pharmaceuticalscategory· March 21, 2025 Brazil's Hypera to launch an Ozempic generic in 2026, CEO says Brazilian drugmaker Hypera plans to launch next year a generic version of ...

Hypera SA (HYPMY) achieved a 9% increase in sellout for 2024, with significant growth in the institutional non-retail market at 26%. The company successfully launched over 50 new products in 2024 ...